These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 19537931)
1. Glycotoxines, carbonyl stress and relevance to diabetes and its complications. Turk Z Physiol Res; 2010; 59(2):147-156. PubMed ID: 19537931 [TBL] [Abstract][Full Text] [Related]
2. Methylglyoxal, diabetes mellitus and diabetic complications. Vander Jagt DL Drug Metabol Drug Interact; 2008; 23(1-2):93-124. PubMed ID: 18533366 [TBL] [Abstract][Full Text] [Related]
3. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Thornalley PJ; Langborg A; Minhas HS Biochem J; 1999 Nov; 344 Pt 1(Pt 1):109-16. PubMed ID: 10548540 [TBL] [Abstract][Full Text] [Related]
4. Methylglyoxal and Advanced Glycation End Products in Patients with Diabetes - What We Know so Far and the Missing Links. Groener JB; Oikonomou D; Cheko R; Kender Z; Zemva J; Kihm L; Muckenthaler M; Peters V; Fleming T; Kopf S; Nawroth PP Exp Clin Endocrinol Diabetes; 2019 Sep; 127(8):497-504. PubMed ID: 28407670 [TBL] [Abstract][Full Text] [Related]
5. Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer. Bellier J; Nokin MJ; Lardé E; Karoyan P; Peulen O; Castronovo V; Bellahcène A Diabetes Res Clin Pract; 2019 Feb; 148():200-211. PubMed ID: 30664892 [TBL] [Abstract][Full Text] [Related]
6. Endogenous alpha-oxoaldehydes and formation of protein and nucleotide advanced glycation endproducts in tissue damage. Thornalley PJ Novartis Found Symp; 2007; 285():229-43; discussion 243-6. PubMed ID: 17590998 [TBL] [Abstract][Full Text] [Related]
7. Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention. Brings S; Fleming T; Freichel M; Muckenthaler MU; Herzig S; Nawroth PP Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475116 [TBL] [Abstract][Full Text] [Related]
8. Edaravone protected human brain microvascular endothelial cells from methylglyoxal-induced injury by inhibiting AGEs/RAGE/oxidative stress. Li W; Xu H; Hu Y; He P; Ni Z; Xu H; Zhang Z; Dai H PLoS One; 2013; 8(9):e76025. PubMed ID: 24098758 [TBL] [Abstract][Full Text] [Related]
9. Consequences of Dicarbonyl Stress on Skeletal Muscle Proteins in Type 2 Diabetes. Ahmad K; Shaikh S; Lee EJ; Lee YH; Choi I Curr Protein Pept Sci; 2020; 21(9):878-889. PubMed ID: 31746292 [TBL] [Abstract][Full Text] [Related]
10. Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation. Ruggiero-Lopez D; Lecomte M; Moinet G; Patereau G; Lagarde M; Wiernsperger N Biochem Pharmacol; 1999 Dec; 58(11):1765-73. PubMed ID: 10571251 [TBL] [Abstract][Full Text] [Related]
11. Chemistry and pathobiology of advanced glycation end products. Schleicher ED; Bierhaus A; Häring HU; Nawroth PP; Lehmann R Contrib Nephrol; 2001; (131):1-9. PubMed ID: 11125554 [No Abstract] [Full Text] [Related]
12. Advanced glycation: a novel outlook on atherosclerosis. Price CL; Knight SC Curr Pharm Des; 2007; 13(36):3681-7. PubMed ID: 18220806 [TBL] [Abstract][Full Text] [Related]
13. Carbonyl stress in diabetics with acute coronary syndrome. Bora S; Shankarrao Adole P Clin Chim Acta; 2021 Sep; 520():78-86. PubMed ID: 34090879 [TBL] [Abstract][Full Text] [Related]
14. Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging. Babizhayev MA; Deyev AI; Savel'yeva EL; Lankin VZ; Yegorov YE J Dermatolog Treat; 2012 Oct; 23(5):345-84. PubMed ID: 21756141 [TBL] [Abstract][Full Text] [Related]
15. Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression. Lin JA; Wu CH; Lu CC; Hsia SM; Yen GC Mol Nutr Food Res; 2016 Aug; 60(8):1850-64. PubMed ID: 26774083 [TBL] [Abstract][Full Text] [Related]
17. Further characterization of the Maillard deglycase DJ-1 and its prokaryotic homologs, deglycase 1/Hsp31, deglycase 2/YhbO, and deglycase 3/YajL. Richarme G; Abdallah J; Mathas N; Gautier V; Dairou J Biochem Biophys Res Commun; 2018 Sep; 503(2):703-709. PubMed ID: 29932913 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of alpha-oxoaldehydes during oxidative stress: a role in cytotoxicity. Abordo EA; Minhas HS; Thornalley PJ Biochem Pharmacol; 1999 Aug; 58(4):641-8. PubMed ID: 10413301 [TBL] [Abstract][Full Text] [Related]
19. Methylglyoxal and advanced glycation endproducts: new therapeutic horizons? Desai K; Wu L Recent Pat Cardiovasc Drug Discov; 2007 Jun; 2(2):89-99. PubMed ID: 18221107 [TBL] [Abstract][Full Text] [Related]
20. 3-Deoxyglucosone: a potential glycating agent accountable for structural alteration in H3 histone protein through generation of different AGEs. Ashraf JM; Ahmad S; Rabbani G; Hasan Q; Jan AT; Lee EJ; Khan RH; Alam K; Choi I PLoS One; 2015; 10(2):e0116804. PubMed ID: 25689368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]